# 逐題詳解 [上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/60/) 第 61 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/62/) 全部36000題詳解已提供中英顯示、基本符號及結構檢查，且第1–36000題已全部完成第二對話數理與中英語義覆核；不再有顯示／符號檢查候選。 候選群共 36000 題；已發布 36000 題詳解，其中數理覆核 36000 題、顯示／符號檢查候選 0 題；其餘 0 題尚未在此發布。 - [第 12001 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0001/) · R0023-12001 · 已數理覆核 - [第 12002 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0002/) · R0023-12002 · 已數理覆核 - [第 12003 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0003/) · R0023-12003 · 已數理覆核 - [第 12004 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0004/) · R0023-12004 · 已數理覆核 - [第 12005 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0005/) · R0023-12005 · 已數理覆核 - [第 12006 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0006/) · R0023-12006 · 已數理覆核 - [第 12007 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0007/) · R0023-12007 · 已數理覆核 - [第 12008 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0008/) · R0023-12008 · 已數理覆核 - [第 12009 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0009/) · R0023-12009 · 已數理覆核 - [第 12010 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0010/) · R0023-12010 · 已數理覆核 - [第 12011 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0011/) · R0023-12011 · 已數理覆核 - [第 12012 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0012/) · R0023-12012 · 已數理覆核 - [第 12013 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0013/) · R0023-12013 · 已數理覆核 - [第 12014 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0014/) · R0023-12014 · 已數理覆核 - [第 12015 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0015/) · R0023-12015 · 已數理覆核 - [第 12016 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0016/) · R0023-12016 · 已數理覆核 - [第 12017 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0017/) · R0023-12017 · 已數理覆核 - [第 12018 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0018/) · R0023-12018 · 已數理覆核 - [第 12019 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0019/) · R0023-12019 · 已數理覆核 - [第 12020 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0020/) · R0023-12020 · 已數理覆核 - [第 12021 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0021/) · R0023-12021 · 已數理覆核 - [第 12022 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0022/) · R0023-12022 · 已數理覆核 - [第 12023 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0023/) · R0023-12023 · 已數理覆核 - [第 12024 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0024/) · R0023-12024 · 已數理覆核 - [第 12025 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0025/) · R0023-12025 · 已數理覆核 - [第 12026 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0076/) · R0023-12026 · 已數理覆核 - [第 12027 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0077/) · R0023-12027 · 已數理覆核 - [第 12028 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0078/) · R0023-12028 · 已數理覆核 - [第 12029 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0079/) · R0023-12029 · 已數理覆核 - [第 12030 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0080/) · R0023-12030 · 已數理覆核 - [第 12031 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0081/) · R0023-12031 · 已數理覆核 - [第 12032 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0082/) · R0023-12032 · 已數理覆核 - [第 12033 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0083/) · R0023-12033 · 已數理覆核 - [第 12034 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0084/) · R0023-12034 · 已數理覆核 - [第 12035 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0085/) · R0023-12035 · 已數理覆核 - [第 12036 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0086/) · R0023-12036 · 已數理覆核 - [第 12037 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0087/) · R0023-12037 · 已數理覆核 - [第 12038 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0088/) · R0023-12038 · 已數理覆核 - [第 12039 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0089/) · R0023-12039 · 已數理覆核 - [第 12040 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0090/) · R0023-12040 · 已數理覆核 - [第 12041 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0091/) · R0023-12041 · 已數理覆核 - [第 12042 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0092/) · R0023-12042 · 已數理覆核 - [第 12043 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0093/) · R0023-12043 · 已數理覆核 - [第 12044 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0094/) · R0023-12044 · 已數理覆核 - [第 12045 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0095/) · R0023-12045 · 已數理覆核 - [第 12046 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0096/) · R0023-12046 · 已數理覆核 - [第 12047 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0097/) · R0023-12047 · 已數理覆核 - [第 12048 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0098/) · R0023-12048 · 已數理覆核 - [第 12049 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0099/) · R0023-12049 · 已數理覆核 - [第 12050 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0100/) · R0023-12050 · 已數理覆核 - [第 12051 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0026/) · R0023-12051 · 已數理覆核 - [第 12052 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0027/) · R0023-12052 · 已數理覆核 - [第 12053 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0028/) · R0023-12053 · 已數理覆核 - [第 12054 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0029/) · R0023-12054 · 已數理覆核 - [第 12055 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0030/) · R0023-12055 · 已數理覆核 - [第 12056 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0031/) · R0023-12056 · 已數理覆核 - [第 12057 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0032/) · R0023-12057 · 已數理覆核 - [第 12058 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0033/) · R0023-12058 · 已數理覆核 - [第 12059 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0034/) · R0023-12059 · 已數理覆核 - [第 12060 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0035/) · R0023-12060 · 已數理覆核 - [第 12061 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0036/) · R0023-12061 · 已數理覆核 - [第 12062 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0037/) · R0023-12062 · 已數理覆核 - [第 12063 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0038/) · R0023-12063 · 已數理覆核 - [第 12064 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0039/) · R0023-12064 · 已數理覆核 - [第 12065 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0040/) · R0023-12065 · 已數理覆核 - [第 12066 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0041/) · R0023-12066 · 已數理覆核 - [第 12067 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0042/) · R0023-12067 · 已數理覆核 - [第 12068 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0043/) · R0023-12068 · 已數理覆核 - [第 12069 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0044/) · R0023-12069 · 已數理覆核 - [第 12070 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0045/) · R0023-12070 · 已數理覆核 - [第 12071 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0046/) · R0023-12071 · 已數理覆核 - [第 12072 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0047/) · R0023-12072 · 已數理覆核 - [第 12073 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0048/) · R0023-12073 · 已數理覆核 - [第 12074 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0049/) · R0023-12074 · 已數理覆核 - [第 12075 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0050/) · R0023-12075 · 已數理覆核 - [第 12076 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0051/) · R0023-12076 · 已數理覆核 - [第 12077 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0052/) · R0023-12077 · 已數理覆核 - [第 12078 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0053/) · R0023-12078 · 已數理覆核 - [第 12079 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0054/) · R0023-12079 · 已數理覆核 - [第 12080 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0055/) · R0023-12080 · 已數理覆核 - [第 12081 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0056/) · R0023-12081 · 已數理覆核 - [第 12082 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0057/) · R0023-12082 · 已數理覆核 - [第 12083 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0058/) · R0023-12083 · 已數理覆核 - [第 12084 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0059/) · R0023-12084 · 已數理覆核 - [第 12085 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0060/) · R0023-12085 · 已數理覆核 - [第 12086 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0061/) · R0023-12086 · 已數理覆核 - [第 12087 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0062/) · R0023-12087 · 已數理覆核 - [第 12088 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0063/) · R0023-12088 · 已數理覆核 - [第 12089 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0064/) · R0023-12089 · 已數理覆核 - [第 12090 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0065/) · R0023-12090 · 已數理覆核 - [第 12091 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0066/) · R0023-12091 · 已數理覆核 - [第 12092 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0067/) · R0023-12092 · 已數理覆核 - [第 12093 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0068/) · R0023-12093 · 已數理覆核 - [第 12094 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0069/) · R0023-12094 · 已數理覆核 - [第 12095 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0070/) · R0023-12095 · 已數理覆核 - [第 12096 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0071/) · R0023-12096 · 已數理覆核 - [第 12097 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0072/) · R0023-12097 · 已數理覆核 - [第 12098 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0073/) · R0023-12098 · 已數理覆核 - [第 12099 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0074/) · R0023-12099 · 已數理覆核 - [第 12100 題：有限阿貝爾群](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r01-finite-abelian-group-0075/) · R0023-12100 · 已數理覆核 - [第 12101 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0076/) · R0023-12101 · 已數理覆核 - [第 12102 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0077/) · R0023-12102 · 已數理覆核 - [第 12103 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0078/) · R0023-12103 · 已數理覆核 - [第 12104 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0079/) · R0023-12104 · 已數理覆核 - [第 12105 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0080/) · R0023-12105 · 已數理覆核 - [第 12106 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0081/) · R0023-12106 · 已數理覆核 - [第 12107 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0082/) · R0023-12107 · 已數理覆核 - [第 12108 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0083/) · R0023-12108 · 已數理覆核 - [第 12109 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0084/) · R0023-12109 · 已數理覆核 - [第 12110 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0085/) · R0023-12110 · 已數理覆核 - [第 12111 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0086/) · R0023-12111 · 已數理覆核 - [第 12112 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0087/) · R0023-12112 · 已數理覆核 - [第 12113 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0088/) · R0023-12113 · 已數理覆核 - [第 12114 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0089/) · R0023-12114 · 已數理覆核 - [第 12115 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0090/) · R0023-12115 · 已數理覆核 - [第 12116 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0091/) · R0023-12116 · 已數理覆核 - [第 12117 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0092/) · R0023-12117 · 已數理覆核 - [第 12118 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0093/) · R0023-12118 · 已數理覆核 - [第 12119 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0094/) · R0023-12119 · 已數理覆核 - [第 12120 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0095/) · R0023-12120 · 已數理覆核 - [第 12121 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0096/) · R0023-12121 · 已數理覆核 - [第 12122 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0097/) · R0023-12122 · 已數理覆核 - [第 12123 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0098/) · R0023-12123 · 已數理覆核 - [第 12124 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0099/) · R0023-12124 · 已數理覆核 - [第 12125 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0100/) · R0023-12125 · 已數理覆核 - [第 12126 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0001/) · R0023-12126 · 已數理覆核 - [第 12127 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0002/) · R0023-12127 · 已數理覆核 - [第 12128 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0003/) · R0023-12128 · 已數理覆核 - [第 12129 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0004/) · R0023-12129 · 已數理覆核 - [第 12130 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0005/) · R0023-12130 · 已數理覆核 - [第 12131 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0006/) · R0023-12131 · 已數理覆核 - [第 12132 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0007/) · R0023-12132 · 已數理覆核 - [第 12133 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0008/) · R0023-12133 · 已數理覆核 - [第 12134 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0009/) · R0023-12134 · 已數理覆核 - [第 12135 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0010/) · R0023-12135 · 已數理覆核 - [第 12136 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0011/) · R0023-12136 · 已數理覆核 - [第 12137 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0012/) · R0023-12137 · 已數理覆核 - [第 12138 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0013/) · R0023-12138 · 已數理覆核 - [第 12139 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0014/) · R0023-12139 · 已數理覆核 - [第 12140 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0015/) · R0023-12140 · 已數理覆核 - [第 12141 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0016/) · R0023-12141 · 已數理覆核 - [第 12142 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0017/) · R0023-12142 · 已數理覆核 - [第 12143 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0018/) · R0023-12143 · 已數理覆核 - [第 12144 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0019/) · R0023-12144 · 已數理覆核 - [第 12145 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0020/) · R0023-12145 · 已數理覆核 - [第 12146 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0021/) · R0023-12146 · 已數理覆核 - [第 12147 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0022/) · R0023-12147 · 已數理覆核 - [第 12148 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0023/) · R0023-12148 · 已數理覆核 - [第 12149 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0024/) · R0023-12149 · 已數理覆核 - [第 12150 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0025/) · R0023-12150 · 已數理覆核 - [第 12151 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0051/) · R0023-12151 · 已數理覆核 - [第 12152 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0052/) · R0023-12152 · 已數理覆核 - [第 12153 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0053/) · R0023-12153 · 已數理覆核 - [第 12154 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0054/) · R0023-12154 · 已數理覆核 - [第 12155 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0055/) · R0023-12155 · 已數理覆核 - [第 12156 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0056/) · R0023-12156 · 已數理覆核 - [第 12157 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0057/) · R0023-12157 · 已數理覆核 - [第 12158 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0058/) · R0023-12158 · 已數理覆核 - [第 12159 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0059/) · R0023-12159 · 已數理覆核 - [第 12160 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0060/) · R0023-12160 · 已數理覆核 - [第 12161 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0061/) · R0023-12161 · 已數理覆核 - [第 12162 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0062/) · R0023-12162 · 已數理覆核 - [第 12163 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0063/) · R0023-12163 · 已數理覆核 - [第 12164 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0064/) · R0023-12164 · 已數理覆核 - [第 12165 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0065/) · R0023-12165 · 已數理覆核 - [第 12166 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0066/) · R0023-12166 · 已數理覆核 - [第 12167 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0067/) · R0023-12167 · 已數理覆核 - [第 12168 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0068/) · R0023-12168 · 已數理覆核 - [第 12169 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0069/) · R0023-12169 · 已數理覆核 - [第 12170 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0070/) · R0023-12170 · 已數理覆核 - [第 12171 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0071/) · R0023-12171 · 已數理覆核 - [第 12172 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0072/) · R0023-12172 · 已數理覆核 - [第 12173 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0073/) · R0023-12173 · 已數理覆核 - [第 12174 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0074/) · R0023-12174 · 已數理覆核 - [第 12175 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0075/) · R0023-12175 · 已數理覆核 - [第 12176 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0026/) · R0023-12176 · 已數理覆核 - [第 12177 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0027/) · R0023-12177 · 已數理覆核 - [第 12178 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0028/) · R0023-12178 · 已數理覆核 - [第 12179 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0029/) · R0023-12179 · 已數理覆核 - [第 12180 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0030/) · R0023-12180 · 已數理覆核 - [第 12181 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0031/) · R0023-12181 · 已數理覆核 - [第 12182 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0032/) · R0023-12182 · 已數理覆核 - [第 12183 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0033/) · R0023-12183 · 已數理覆核 - [第 12184 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0034/) · R0023-12184 · 已數理覆核 - [第 12185 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0035/) · R0023-12185 · 已數理覆核 - [第 12186 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0036/) · R0023-12186 · 已數理覆核 - [第 12187 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0037/) · R0023-12187 · 已數理覆核 - [第 12188 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0038/) · R0023-12188 · 已數理覆核 - [第 12189 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0039/) · R0023-12189 · 已數理覆核 - [第 12190 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0040/) · R0023-12190 · 已數理覆核 - [第 12191 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0041/) · R0023-12191 · 已數理覆核 - [第 12192 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0042/) · R0023-12192 · 已數理覆核 - [第 12193 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0043/) · R0023-12193 · 已數理覆核 - [第 12194 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0044/) · R0023-12194 · 已數理覆核 - [第 12195 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0045/) · R0023-12195 · 已數理覆核 - [第 12196 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0046/) · R0023-12196 · 已數理覆核 - [第 12197 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0047/) · R0023-12197 · 已數理覆核 - [第 12198 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0048/) · R0023-12198 · 已數理覆核 - [第 12199 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0049/) · R0023-12199 · 已數理覆核 - [第 12200 題：Cauchy序列](https://ocme.evemisslab.com/zh-Hant/questions/q-20261013-advance-20261026-r03-cauchy-sequence-0050/) · R0023-12200 · 已數理覆核 原題庫保留原有候選與驗證標記；顯示與符號檢查不記作數學複審或獨立重算。 [完整出版目錄 JSON](https://ocme.evemisslab.com/data/question-derivations/publication.json) · [數理覆核索引 JSON](https://ocme.evemisslab.com/data/question-derivations/index.json)[上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/60/) 第 61 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/62/)